Skip to main content

Table 3 Total infected cases, decompensated cirrhosis, HCC and liver-related deaths in Turkey, by scenario, 2015 and 2030

From: A micro-elimination approach to addressing hepatitis C in Turkey

 

2015

2030

Total viremic infections

 Base

278,000

177,000

 Increased treatment

278,000

142,000

 WHO targets

278,000

52,000

Prevalent Decompensated cirrhosis

 Base

1500

1300

 Increased treatment

1500

700

 WHO targets

1500

290

Prevalent Hepatocellular carcinoma

 Base

990

750

 Increased treatment

990

320

 WHO targets

990

170

Liver-related deaths

 Base

1000

900

 Increased treatment

1000

530

 WHO targets

1000

200